References
- PaulMCarmeliYDurante-MangoniECombination therapy for carbapenem-resistant gram-negative bacteriaJ Antimicrob Chemother20146992305230924872346
- FalagasMEVardakasKZTsiveriotisKPTriaridesNATansarliGSEffectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infectionsInt J Antimicrob Agents20144411724602499
- KaraiskosIAntoniadouAGiamarellouHCombination therapy for extensively-drug resistant gram-negative bacteriaExpert Rev Anti Infect Ther201715121123114029172792
- CaiYChuaNGLimTPFrom bench-top to bedside: a prospective in vitro antibiotic combination testing (iACT) service to guide the selection of rationally optimized antimicrobial combinations against extensively drug resistant (XDR) gram negative bacteria (GNB)PLoS One2016117e015874027441603
- Chinese XDR Consensus Working GroupGuanXHeLLaboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant gram-negative bacilli: a Chinese consensus statementClin Microbiol Infect201622Suppl 1S15S2526627340
- GustinettiGMikulskaMBloodstream infections in neutropenic cancer patients: a practical updateVirulence20167328029727002635
- ZhengCTangBZhuXPre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATGAnn Hematol201796111512427771742
- DignanFLClarkAAmroliaPDiagnosis and management of acute graft-versus-host diseaseBr J Haematol20121581304522533831
- XuAZhengBXuYCNational epidemiology of carbapenemresistant and extensively drug-resistant gram-negative bacteria isolated from blood samples in China in 2013Clin Microbiol Infect201622Suppl 1S1S826846351
- FishbainJPelegAYTreatment of Acinetobacter infectionsClin Infect Dis2010511798420504234
- PaulMCarmeliYDurante-MangoniECombination therapy for carbapenem-resistant gram-negative bacteriaJ Antimicrob Chemother20146992305230924872346
- MuralidharanGMicalizziMSpethJRaibleDTroySPharmacokinetics of tigecycline after single and multiple doses in healthy subjectsAntimicrob Agents Chemother200549122022915616299
- RamirezJDartoisNGandjiniHRandomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumoniaAntimicrob Agents Chemother20135741756176223357775
- de PascaleGMontiniLPennisiMHigh dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteriaCrit Care2014183R9024887101